During the past decade, The Center for Clinical Trials conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 20 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 11 clinical trials were completed. i.e. 550% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Center for Clinical Trials" #1 sponsor was "Pfizer" with 5 trials, followed by "Boehringer Ingelheim" with 4 trials sponsored, "BioDelivery Sciences International" with 3 trials sponsored, "AstraZeneca" with 2 trials sponsored and "Allergan" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Center for Clinical Trials" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "The Center for Clinical Trials" are "Low Back Pain" (6 trials), "Osteoarthritis" (3 trials), "Heart Failure" (2 trials), "Type 2 Diabetes" (2 trials) and "Anemia" (1 trials). Many other conditions were trialed in "The Center for Clinical Trials" in a lesser frequency.

Most popular intervention types in "The Center for Clinical Trials" are "Drug" (19 trials), "Biological" (5 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Buprenorphine" (2 trials), "Dapagliflozin" (2 trials), "Empagliflozin" (2 trials) and "Naproxen" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Center for Clinical Trials" are 22 trials for "All" genders.

Currently, there are NaN active trials in "The Center for Clinical Trials". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in The Center for Clinical Trials, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in The Center for Clinical Trials, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".